Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytokinetics

37.64
+1.464.04%
Pre-market: 37.60-0.0400-0.11%04:24 EDT
Volume:1.78M
Turnover:66.95M
Market Cap:4.50B
PE:-7.10
High:38.59
Open:35.68
Low:35.50
Close:36.18
Loading ...

Cytokinetics CEO Makes a Strategic Stock Sale

TIPRANKS
·
8 hours ago

Cytokinetics CEO Robert I. Blum Reports Disposal of Common Shares

Reuters
·
14 hours ago

BRIEF-Cytokinetics To Announce Second Quarter Results On August 7, 2025

Reuters
·
25 Jul

Cytokinetics to Announce Second Quarter Results on August 7, 2025

THOMSON REUTERS
·
25 Jul

Top Executive Sells Cytokinetics Stock in a Major Move

TIPRANKS
·
24 Jul

Cytokinetics EVP Fady Ibraham Malik Reports Disposal of Common Shares

Reuters
·
23 Jul

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
19 Jul

Cytokinetics CEO Makes a Significant Stock Move!

TIPRANKS
·
16 Jul

Robert I. Blum, President & CEO, Reports Disposal of Common Shares in Cytokinetics Inc

Reuters
·
16 Jul

Cytokinetics (CYTK) Gets a Buy from H.C. Wainwright

TIPRANKS
·
14 Jul

Cytokinetics Insiders Sold US$9.5m Of Shares Suggesting Hesitancy

Simply Wall St.
·
12 Jul

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025

GlobeNewswire
·
10 Jul

Top Executive at Cytokinetics Makes Significant Stock Sale

TIPRANKS
·
09 Jul

Fady Ibraham Malik, EVP of Research & Development, Reports Disposal of Cytokinetics Common Shares

Reuters
·
09 Jul

Cytokinetics CEO Makes a Big Move with Stock Sale!

TIPRANKS
·
03 Jul

Robert I. Blum, President & CEO, Reports Disposal of Cytokinetics Common Shares

Reuters
·
03 Jul

BRIEF-Cytokinetics announces inducement grants under Nasdaq listing rule

Reuters
·
18 Jun

Cytokinetics CEO Makes a Significant Stock Sale!

TIPRANKS
·
17 Jun

Robert I. Blum, President & CEO, Reports Disposal of Common Shares of Cytokinetics Inc

Reuters
·
17 Jun

Cytokinetics Is Maintained at Overweight by JP Morgan

Dow Jones
·
09 Jun